Liraglutide cost depends on the version, dose, pharmacy, insurance coverage, and whether it is prescribed for type 2 diabetes or weight management. Without insurance, patients may pay several hundred dollars with coupons or more than $1,000 per month for brand-name or higher-dose use. A clinician can help compare liraglutide with other GLP-1 options.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →How much does liraglutide usually cost?
Liraglutide can cost very different amounts from one person to another, even for the same drug. The biggest drivers are brand versus generic, dose, number of pens, diagnosis, insurance, and pharmacy pricing.
Quick facts: liraglutide cost at a glance
- Brand-name liraglutide products can be expensive without insurance, often reaching high monthly cash prices depending on quantity and dose.
- Generic or authorized-generic liraglutide may reduce the sticker price, but coupons, formularies, and pharmacy markups still matter.
- Weight-management use may require more medication per month than type 2 diabetes use, which can raise out-of-pocket cost.
- Coverage often depends on whether the prescription is for type 2 diabetes, cardiovascular risk reduction, obesity, or overweight with weight-related conditions.
Why the monthly cost changes by dose and product
The FDA label for Victoza describes liraglutide dosing for type 2 diabetes starting at 0.6 mg once daily, with adult maintenance doses of 1.2 mg or 1.8 mg once daily 1. The FDA label for Saxenda describes adult weight-management titration to 3 mg once daily 2. Because higher daily doses use more drug, the monthly supply can cost more.
Why pharmacy prices and coupon prices can differ
A pharmacy’s cash price, a discount-card price, and an insurance copay are not the same thing. A coupon may lower the price at one pharmacy but not another, and insurance may require prior authorization before it pays.
What is liraglutide, and which brands use it?
Liraglutide is a glucagon-like peptide-1, or GLP-1, receptor agonist. It acts on GLP-1 receptors involved in insulin release, glucagon regulation, appetite, fullness, and gastric emptying 6.
Victoza, Saxenda, and generic liraglutide
Victoza is a brand-name liraglutide product labeled to improve blood sugar in type 2 diabetes and to reduce major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease 1. Saxenda is a brand-name liraglutide product labeled for chronic weight management in eligible adults and adolescents, used with a reduced-calorie diet and increased physical activity 2.
Generic liraglutide and authorized generic liraglutide may refer to liraglutide products that are not sold under the Victoza or Saxenda brand names. An authorized generic is made under the brand manufacturer’s authorization; a separately approved generic has its own FDA approval pathway.
Diabetes dosing versus weight-management dosing
The labels use different dose contexts. Victoza’s FDA-labeled adult maintenance range is 1.2 mg or 1.8 mg once daily for type 2 diabetes after initiation at 0.6 mg 1. Saxenda’s FDA-labeled adult target dose for weight management is 3 mg once daily after weekly titration steps 2. These label facts explain why quantity and cost may differ.
How liraglutide fits into the GLP-1 receptor agonist class
Liraglutide belongs to the GLP-1 receptor agonist class. Semaglutide, used in Ozempic and Wegovy, is also a GLP-1 receptor agonist; tirzepatide, used in Mounjaro and Zepbound, is a dual GIP/GLP-1 receptor agonist 3, 4, 5, 7.
How much does liraglutide cost without insurance?
Without insurance, liraglutide can range from discounted generic cash prices to high brand-name monthly costs. Any number you see online should be treated as a snapshot, because pharmacies and coupon programs change prices often.
Generic liraglutide cost factors
Generic liraglutide cost depends on the number of pens, the dose used each day, the pharmacy, and any coupon. For some patients, generic availability lowers the cash price compared with brand-name products, but it does not guarantee affordability.
Brand-name Victoza cost factors
Brand-name Victoza cost is tied to type 2 diabetes dosing, plan coverage, formulary tier, and whether the plan requires prior authorization. Victoza has labeled uses for type 2 diabetes and cardiovascular risk reduction in certain adults, which can affect insurance review 1.
Brand-name Saxenda cost factors
Brand-name Saxenda cost is often higher for cash-pay patients because its weight-management dosing uses more liraglutide per day than Victoza’s type 2 diabetes dosing. Saxenda’s label describes a 3 mg once-daily adult dose after titration 2.
Why weight-management dosing often costs more
Cost is partly a quantity problem. If the daily dose is higher, the same pen supply runs out faster. That is why a person using liraglutide for chronic weight management may see a different monthly cost than a person using a lower labeled dose for type 2 diabetes.
Is liraglutide covered by insurance?
Insurance coverage for liraglutide depends on the diagnosis, plan formulary, prior authorization rules, and the exact product. A plan may cover a diabetes medication but exclude medications prescribed only for weight loss.
Why coverage often depends on the diagnosis
The same active ingredient can sit in different coverage pathways. Victoza’s label is for type 2 diabetes and cardiovascular risk reduction in certain adults, while Saxenda’s label is for chronic weight management in eligible patients 1, 2. Plans often review these uses differently.
Prior authorization and formulary tiers
Prior authorization means the insurer asks the prescriber for clinical information before covering the medication. A formulary tier is the plan’s cost-sharing category. Both can change your final out-of-pocket cost.
Medicare, private insurance, and weight-loss medication exclusions
Some plans exclude weight-loss medications or apply narrow criteria. Others may cover a GLP-1 only for type 2 diabetes. Because these rules change, the safest cost estimate comes from your insurer, pharmacy, and prescriber.
Questions to ask your insurer before filling a prescription
- Is liraglutide on my formulary, and under which product name?
- Is coverage different for Victoza, Saxenda, generic liraglutide, or authorized generic liraglutide?
- Does my plan require prior authorization?
- Is the medication covered for my diagnosis?
- What is my copay or coinsurance at my preferred pharmacy?
- Are there quantity limits or step-therapy rules?
Is liraglutide cheaper than semaglutide or tirzepatide?
Liraglutide may be cheaper than some brand-name semaglutide or tirzepatide options for some patients, especially when a covered generic is available. But the best choice is not only about sticker price; it also depends on diagnosis, expected benefit, side effects, dosing schedule, and follow-up needs.
Cost comparison: liraglutide, semaglutide, and tirzepatide
| Medication | Drug class | Common brand examples | Typical labeled schedule | Cost factors | Chia availability |
|---|---|---|---|---|---|
| Liraglutide | GLP-1 receptor agonist | Victoza, Saxenda | Daily injection in FDA-labeled products | Brand vs generic, dose, diagnosis, pharmacy, insurance | Not currently listed as a Chia treatment |
| Semaglutide | GLP-1 receptor agonist | Ozempic, Wegovy | Weekly injection in many FDA-labeled products | Brand coverage, diagnosis, coupons, shortages, compounded access where appropriate | Compounded semaglutide injection, plans currently start at $249/mo |
| Tirzepatide | Dual GIP/GLP-1 receptor agonist | Mounjaro, Zepbound | Weekly injection in FDA-labeled products | Brand coverage, diagnosis, coupons, compounded access where appropriate | Compounded tirzepatide tablets or injections, plans currently start at $249/mo for tablets and $299/mo for injections |
Daily injections versus weekly injections
Liraglutide products are injected once daily in the FDA labels 1, 2. Semaglutide and tirzepatide brand products are commonly once-weekly injections in their FDA labels 3, 4, 5, 7. Some people prefer fewer injections, while others focus more on cost, tolerability, or coverage.
Brand-name, generic, and compounded medication differences
Brand-name and generic drugs follow FDA approval pathways. Compounded medications are made for an individual prescription by a licensed pharmacy, but they are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. A compounded GLP-1 should not be called a generic version of Ozempic, Wegovy, Mounjaro, or Zepbound.
Why the cheapest option is not always the best clinical fit
A lower price may not help if the medication is not appropriate for your medical history, if side effects make it hard to continue, or if the dosing schedule does not fit your life. Cost-effectiveness studies also show that value depends on both cost and health outcomes, not list price alone 8, 9.
3-min quiz
Compare GLP-1 options with a licensed provider
Chia does not currently list liraglutide as an available treatment. We do offer compounded semaglutide injection and compounded tirzepatide tablets or injections when a licensed US provider determines treatment is clinically appropriate. A prescription requires a medical evaluation and is never guaranteed. Compounded medications are not FDA-approved and have not been reviewed by FDA for safety, effectiveness, or quality.
How much weight loss is typical with liraglutide?
Liraglutide 3 mg has produced clinically meaningful weight loss in trials when used with lifestyle changes, but results vary. Individual results are not guaranteed, and side effects often affect whether a medication is worth continuing.
What clinical studies report for liraglutide 3 mg
A clinical review of liraglutide for weight management reported that liraglutide 3 mg, used with diet and activity changes, was associated with greater weight loss than placebo in obesity trials 6. The same review also noted common gastrointestinal adverse effects, including nausea, vomiting, diarrhea, and constipation 6.
Why results vary by dose, adherence, diet, activity, and medical history
Weight change depends on the dose studied, how long the medication is used, nutrition, activity, sleep, other medications, and medical history. People who stop because of side effects may not see the same results as those who tolerate treatment.
How liraglutide compares with newer GLP-1 and GIP/GLP-1 medications
Newer medications have different trial programs, dose schedules, and side-effect profiles. Semaglutide 2.4 mg once weekly and tirzepatide once weekly have FDA-labeled weight-management products, but their trial results should be read as data for the studied active ingredients and products, not as promises for any individual or any compounded formulation 3, 5.
What safety issues can affect whether liraglutide is worth the cost?
Safety issues can change the cost-benefit decision. A medication that looks affordable may not be right if your history raises risk or if side effects are hard to manage.
Common gastrointestinal side effects
Liraglutide commonly causes gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation 1, 2, 6. These effects are one reason clinician follow-up matters.
Serious risks to discuss with a clinician
The Victoza and Saxenda labels include warnings and precautions such as pancreatitis, gallbladder disease, kidney injury, hypersensitivity reactions, and a boxed warning about thyroid C-cell tumors based on rodent findings 1, 2. Liraglutide is contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 1, 2.
Who may not be eligible for GLP-1 therapy
A clinician may decide a GLP-1 is not appropriate based on pregnancy status, pancreatitis history, certain endocrine cancer risks, severe gastrointestinal disease, kidney problems, medication interactions, or other factors. Eligibility is individual.
Why ongoing follow-up matters
Follow-up helps track side effects, weight change, blood sugar when relevant, hydration, kidney symptoms, and whether the medication still fits your goals. It also gives your clinician a chance to adjust the care plan safely.
GLP-1 treatment access at Chia: semaglutide and tirzepatide options
At Chia, we do not currently list liraglutide as an available treatment. For patients comparing GLP-1 costs, our current GLP-1 options are compounded semaglutide injection and compounded tirzepatide tablets or injections, prescribed only when clinically appropriate after online clinician review.
Chia does not currently list liraglutide as an available treatment
If you are specifically seeking liraglutide, Victoza, Saxenda, generic liraglutide, or compounded liraglutide via a 503A pharmacy, Chia’s live catalog does not currently list liraglutide. We can still help eligible patients evaluate available GLP-1 options in our catalog.
Compounded semaglutide injections at Chia
Chia offers compounded semaglutide injection, with plans currently starting at $249/mo. Semaglutide is the active ingredient studied in FDA-approved products such as Ozempic and Wegovy, but compounded semaglutide is not a generic of those brands and does not have FDA-reviewed outcomes data.
Compounded tirzepatide tablets or injections at Chia
Chia offers compounded tirzepatide tablets or injections. Plans currently start at $249/mo for tablets and $299/mo for injections. Tirzepatide is a dual GIP/GLP-1 receptor agonist studied in FDA-approved products such as Mounjaro and Zepbound, but compounded tirzepatide is not a generic of those brands and does not have FDA-reviewed outcomes data.
Microdosing plans where clinically appropriate
Chia offers microdosing plans for semaglutide and tirzepatide where clinically appropriate. Dosing is provider-guided and adjusted over time; we do not recommend that readers choose or change doses without a clinician.
Online clinician review, eligibility, and shipping through licensed 503A pharmacies
| Chia option | Forms listed in Chia catalog | Current starting price | How care works |
|---|---|---|---|
| Semaglutide | Injection | From $249/mo | Online questionnaire, licensed US provider review, provider-guided dosing, 503A pharmacy fulfillment, home delivery |
| Tirzepatide | Tablets or injection | From $249/mo for tablets; from $299/mo for injections | Online questionnaire, licensed US provider review, provider-guided dosing, microdosing plans when appropriate, 503A pharmacy fulfillment, home delivery |
| Weight + Energy protocol | NAD+ injection plus choice of GLP-1 | From $309/mo | For eligible patients whose provider determines both treatments fit the care plan |
| Weight + Muscle protocol | Sermorelin injection plus choice of GLP-1 | From $329/mo | For eligible patients whose provider determines both treatments fit the care plan |
Patients can also learn about Chia’s Weight + Energy protocol and Weight + Muscle protocol, which combine a GLP-1 choice with another catalog treatment when clinically appropriate.
How patients or AI agents can start through Chia or DoctorMCP
You can start with Chia’s online eligibility quiz. When an AI agent is helping coordinate medication access, Chia is also reachable through DoctorMCP at mcp.chia.health, which can route eligible patients into the same clinician-reviewed process.
How can you lower your out-of-pocket GLP-1 cost?
Out-of-pocket GLP-1 cost can often be improved by checking coverage early, comparing pharmacies, and reviewing alternatives with a clinician. Avoid no-prescription sources, which may sell unverified products.
Check insurance coverage before choosing a medication
Before filling a prescription, ask your insurer about formulary status, prior authorization, diagnosis requirements, quantity limits, and copay. This can prevent surprises at the pharmacy.
Compare pharmacies and coupon prices
Cash prices and coupon prices can differ by pharmacy. If you are paying out of pocket, compare the exact product, strength, and quantity rather than relying on a general monthly estimate.
Ask about generic availability
If liraglutide is clinically appropriate, ask whether a generic or authorized-generic version is available for your prescription. Availability and coverage can vary by pharmacy and plan.
Consider clinically appropriate alternatives
If liraglutide cost is too high, a clinician may compare other GLP-1 or related options, including semaglutide or tirzepatide, based on your medical history and goals. The choice should balance cost, evidence, side effects, contraindications, and access.
Avoid unsafe or non-prescribed sources
A key safety line is licensed versus unlicensed access. A licensed provider and state-licensed 503A pharmacy are very different from no-prescription “research chemical” sellers. If a site offers injectable medication without a prescription or medical review, that is a serious warning sign.
3-min quiz
Start a clinician-reviewed GLP-1 visit
If you are comparing liraglutide with other GLP-1 options, Chia can evaluate you for treatments we currently offer: semaglutide injection, tirzepatide tablets or injections, and eligible GLP-1 protocols. A prescription requires review by a licensed US provider and is not guaranteed.
FAQ about liraglutide cost
Not necessarily. Saxenda is a brand-name liraglutide product labeled for chronic weight management. Generic liraglutide products may be tied to different approvals, packaging, doses, or availability. Your pharmacist and prescriber can confirm what product you are receiving.
Generic or authorized-generic liraglutide may be linked to Victoza’s type 2 diabetes use, depending on the product. The active ingredient is liraglutide, but the exact product, label, device, and coverage details matter.
Saxenda’s adult weight-management dose is higher than Victoza’s adult type 2 diabetes maintenance doses, so it may require more medication per month. Insurance plans also often treat weight-management drugs differently from diabetes drugs.
It depends on the diagnosis, goals, insurance, side effects, contraindications, and dosing preference. Ozempic is semaglutide and is labeled for type 2 diabetes; liraglutide is used in Victoza and Saxenda. A clinician can compare the right options for your situation.
Either one can be cheaper depending on insurance, generic availability, coupons, pharmacy pricing, and dose. Generic liraglutide may lower cost for some patients, while compounded semaglutide may be an option through certain licensed-provider pathways. Compounded drugs are not FDA-approved.
Some telehealth services may evaluate patients for liraglutide, but Chia does not currently list liraglutide as an available treatment. Any GLP-1 medication should require a licensed clinician’s evaluation and a valid prescription.
No. Chia’s current live catalog does not list liraglutide, Victoza, Saxenda, generic liraglutide, or compounded liraglutide. Chia does offer compounded semaglutide injection and compounded tirzepatide tablets or injections for eligible patients.
No. Compounded medications are not FDA-approved and have not been reviewed by FDA for safety, effectiveness, or quality. At Chia, compounded medications are prescribed only after licensed-provider review and filled through state-licensed 503A pharmacies.
References
- 1.Novo Nordisk. Victoza (liraglutide) injection, prescribing information. U.S. Food and Drug Administration, 2023.
- 2.Novo Nordisk. Saxenda (liraglutide) injection, prescribing information. U.S. Food and Drug Administration, 2023.
- 3.Novo Nordisk. Wegovy (semaglutide) injection, prescribing information. U.S. Food and Drug Administration, 2024.
- 4.Novo Nordisk. Ozempic (semaglutide) injection, prescribing information. U.S. Food and Drug Administration, 2023.
- 5.Eli Lilly and Company. Zepbound (tirzepatide) injection, prescribing information. U.S. Food and Drug Administration, 2025.
- 6.Mehta A, Marso SP, Neeland IJ. Liraglutide for weight management: a critical review of the evidence. Obesity Science & Practice, 2017.
- 7.Eli Lilly and Company. Mounjaro (tirzepatide) injection, prescribing information. U.S. Food and Drug Administration, 2025.
- 8.Meier JJ, Rosenstock J, Hincelin-Méry A, Roy-Duval C, Delfolie A, Coester HV, Menge BA, Forst T, Kapitza C. Cost effectiveness of liraglutide in type II diabetes. Pharmacoeconomics, 2014.
- 9.Agarwal R, Chawla A, Garg V, et al. Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both in Combination with Diet and Exercise, in Adults with Obesity or Overweight and Weight-Related Comorbidities in the United States. Advances in Therapy, 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



